St. John's University College of Pharmacy and Health Sciences

Are you interested?

featured image
Private (proprietary)
Graduate Programs
Total Full-Time Tuition
varies by program
Graduate Students

« Back to Search

An Inside Look

College of Pharmacy and Health Sciences

Profile Image


Master of Science
• Biological & Pharmaceutical Biotechnology
• Pharmaceutical Sciences
• Pharmacy Administration
• Physician Assistant
• Toxicology

Master of Public Health
• Public Health

Doctoral Degrees
• MS/PhD in Pharmaceutical Sciences
• PhD in Pharmaceutical Sciences

• Department of Clinical Health Professions
• Department of Pharmaceutical Sciences
• Department of Pharmacy Administration & Public Health
• Health Education Resource Center
• EMS Institute
• Institute for Biotechnology

Since its founding in 1929, the College of Pharmacy & Health Sciences at St. John’s University has trained scholars and practitioners who are respected for the quality of their contributions and compassion for those they serve. The College’s advanced degree programs rely on original research and discovery through rigorous scientific investigation to help students advance their understanding of the world.

Evolving technologies
In 2018, the College of Pharmacy and Health Sciences announced the acquisition of new Anatomage virtual dissection tables at the University’s Queens campus and Dr. Andrew J. Bartilucci Center. The Anatomage is the world’s first and most technologically advanced virtual dissection table for anatomy education, effectively replacing expensive and cumbersome cadaver laboratories.

Research is key
Grants for the College have amassed over the years. Most recently, Assistant Professor Vivek Gupta, PhD, obtained two grants from the American Heart Association (AHA) and the National Institutes of Health (NIH) totaling more than $600,000 for his research in treating pulmonary hypertension.

The two-year $154,000 AHA grant will screen drugs already approved by the FDA against cells isolated from patients who suffer from the disease to observe the drugs’ impact on pulmonary hypertension symptoms. Instead of a 15–20-year process, Dr. Gupta said the potential exists for it to take only two to three years to reach the market. The drugs will be screened using robotics, which could also reduce the cost by 60%–70%.

The three-year $492,000 NIH grant is derived from research Dr. Gupta already conducted regarding the antimalarial drug Amodiaquine to treat pulmonary hypertension. Dr. Gupta said he will be able to conduct preclinical trials to test its efficacy. The hope is that  it’ll reverse the effects of the condition. 

Are you interested?

Yes, connect me!

6 Graduate Programs Offered

Program Certificate Master's Doctorate
Campus Hybrid Online Campus Hybrid Online Campus Hybrid Online
Pharmaceutical Science              
Pharmacy Administration                
Physician Assistant                
Public Health                


CollegeXpress Logo


Are you our next winner?

Register now for our scholarship giveaway

Student Body

Not reported


Application Fee
*may vary by program
Housing Offered? N/A


Admissions Office
P: 719 990-2000